Virus-like vesicles of Kaposi's sarcoma-associated herpesvirus activate lytic replication by triggering differentiation signaling

Journal of Virology

Volumn 91, Issue 15, 2017, Pages

  Gong, Danyang ^a   Dai, Xinghong ^a   Xiao, Yuchen ^b   Du, Yushen ^a   Chapa, Travis J ^a   Johnson, Jeffrey R ^c   Li, Xinmin ^b   Krogan, Nevan J ^c   Deng, Hongyu ^d   Wu, Ting Ting ^a   Sun, Ren ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d INSTITUTE OF BIOPHYSICS   (China)

Author keywords

EBV; Envelope protein; Extracellular vesicle; Herpesvirus; KSHV; MicroRNA; PRDM1; RTA; Tegument protein; Virus like vesicle

Indexed keywords

B LYMPHOCYTE INDUCED MATURATION PROTEIN 1; CAPSID PROTEIN; MICRORNA; VIRUS GLYCOPROTEIN; IMMEDIATE EARLY PROTEIN; PRDM1 PROTEIN, HUMAN; REPRESSOR PROTEIN; RTA PROTEIN, HUMAN HERPESVIRUS 8; TRANSACTIVATOR PROTEIN; VIROSOME;

ARTICLE; CELL COMPARTMENTALIZATION; CELL DIFFERENTIATION; CONTROLLED STUDY; GENE EXPRESSION; GENOME ANALYSIS; HERPES VIRUS INFECTION; HUMAN HERPESVIRUS 8; MASS SPECTROMETRY; NONHUMAN; PRIORITY JOURNAL; PROTEOMICS; RNA SEQUENCE; SIGNAL TRANSDUCTION; UPREGULATION; VIRUS CELL INTERACTION; VIRUS ENTRY; VIRUS EXPRESSION; VIRUS ISOLATION; VIRUS PARTICLE; VIRUS PURIFICATION; VIRUS REPLICATION; BIOSYNTHESIS; CELL LINE; CHEMISTRY; GENE EXPRESSION REGULATION; HOST PATHOGEN INTERACTION; HUMAN; METABOLISM; PHYSIOLOGY;

CELL DIFFERENTIATION; CELL LINE; GENE EXPRESSION REGULATION, VIRAL; HERPESVIRUS 8, HUMAN; HOST-PATHOGEN INTERACTIONS; HUMANS; IMMEDIATE-EARLY PROTEINS; REPRESSOR PROTEINS; SIGNAL TRANSDUCTION; TRANS-ACTIVATORS; UP-REGULATION; VIROSOMES; VIRUS REPLICATION;

EID: 85023175514     PISSN: 0022538X     EISSN: 10985514     Source Type: Journal    
DOI: 10.1128/JVI.00362-17     Document Type: Article

References (65)

1. Meckes DG, Jr, Gunawardena HP, Dekroon RM, Heaton PR, Edwards RH, Ozgur S, Griffith JD, Damania B, Raab-Traub N. 2013. Modulation of B-cell exosome proteins by gamma herpesvirus infection. Proc Natl Acad Sci U S A 110:E2925-E2933. https://doi.org/10.1073/pnas.1303906110
2. Yáñez-Mó M, Siljander PRM, Andreu Z, Zavec AB, Borras FE, Buzas EI, Buzas K, Casal E, Cappello F, Carvalho J, Colas E, Cordeiro-da Silva A, Fais S, Falcon-Perez JM, Ghobrial IM, Giebel B, Gimona M, Graner M, Gursel I, Gursel M, Heegaard NHH, Hendrix A, Kierulf P, Kokubun K, Kosanovic M, Kralj-Iglic V, Kramer-Albers EM, Laitinen S, Lasser C, Lener T, Ligeti E, Line A, Lipps G, Llorente A, Lotvall J, Mancek-Keber M, Marcilla A, Mittelbrunn M, Nazarenko I, Nolte-'t Hoen ENM, Nyman TA, O'Driscoll L, Olivan M, Oliveira C, Pallinger E, del Portillo HA, Reventos J, Rigau M, Rohde E, Sammar M, et al. 2015. Biological properties of extracellular vesicles and their physiological functions. J Extracell Vesicles 4:27066. https://doi.org/ 10.3402/jev.v4.27066
3. Raposo G, Stoorvogel W. 2013. Extracellular vesicles: exosomes, microvesicles, and friends. J Cell Biol 200:373-383. https://doi.org/10.1083/ jcb.201211138
4. Nolte-'t Hoen E, Cremer T, Gallo RC, Margolis LB. 2016. Extracellular vesicles and viruses: are they close relatives? Proc Natl Acad Sci U S A 113:9155-9161. https://doi.org/10.1073/pnas.1605146113
5. Meckes DG, Jr, Raab-Traub N. 2011. Microvesicles and viral infection. J Virol 85:12844-12854. https://doi.org/10.1128/JVI.05853-11
6. Kalamvoki M, Deschamps T. 2016. Extracellular vesicles during herpes simplex virus type 1 infection: an inquire. Virol J 13:63. https://doi.org/ 10.1186/s12985-016-0518-2
7. Szilágyi JF, Cunningham C. 1991. Identification and characterization of a novel non-infectious herpes simplex virus-related particle. J Gen Virol 72(Part 3):661-668. https://doi.org/10.1099/0022-1317-72-3-661
8. Craighead JE, Kanich RE, Almeida JD. 1972. Nonviral microbodies with viral antigenicity produced in cytomegalovirus-infected cells. J Virol 10:766-775
9. Chai N, Chang HE, Nicolas E, Han Z, Jarnik M, Taylor J. 2008. Properties of subviral particles of hepatitis B virus. J Virol 82:7812-7817. https://doi.org/10.1128/JVI.00561-08
10. Gastaminza P, Dryden KA, Boyd B, Wood MR, Law M, Yeager M, Chisari FV. 2010. Ultrastructural and biophysical characterization of hepatitis C virus particles produced in cell culture. J Virol 84:10999-11009. https:// doi.org/10.1128/JVI.00526-10
11. Cantin R, Diou J, Belanger D, Tremblay AM, Gilbert C. 2008. Discrimination between exosomes and HIV-1: purification of both vesicles from cell-free supernatants. J Immunol Methods 338:21-30. https://doi.org/ 10.1016/j.jim.2008.07.007
12. Spehner D, Drillien R. 2008. Extracellular vesicles containing virusencoded membrane proteins are a byproduct of infection with modified vaccinia virus Ankara. Virus Res 137:129-136. https://doi.org/10.1016/j.virusres.2008.07.003
13. McLauchlan J, Addison C, Craigie MC, Rixon FJ. 1992. Noninfectious L-particles supply functions which can facilitate infection by HSV-1. Virology 190:682-688. https://doi.org/10.1016/0042-6822(92)90906-6
14. Sauer C, Klobuch S, Herr W, Thomas S, Plachter B. 2013. Subviral dense bodies of human cytomegalovirus stimulate maturation and activation of monocyte-derived immature dendritic cells. J Virol 87:11287-11291. https://doi.org/10.1128/JVI.01429-13
15. Reynolds TD, Buonocore L, Rose NF, Rose JK, Robek MD. 2015. Virus-like vesicle-based therapeutic vaccine vectors for chronic hepatitis B virus infection. J Virol 89:10407-10415. https://doi.org/10.1128/JVI.01184-15
16. Rose NF, Buonocore L, Schell JB, Chattopadhyay A, Bahl K, Liu X, Rose JK. 2014. In vitro evolution of high-titer, virus-like vesicles containing a single structural protein. Proc Natl Acad Sci U S A 111:16866-16871. https://doi.org/10.1073/pnas.1414991111
17. Becke S, Aue S, Thomas D, Schader S, Podlech J, Bopp T, Sedmak T, Wolfrum U, Plachter B, Reyda S. 2010. Optimized recombinant dense bodies of human cytomegalovirus efficiently prime virus specific lymphocytes and neutralizing antibodies without the addition of adjuvant. Vaccine 28:6191-6198. https://doi.org/10.1016/j.vaccine.2010.07.016
18. Cayatte C, Schneider-Ohrum K, Wang ZT, Irrinki A, Nguyen N, Lu J, Nelson C, Servat E, Gemmell L, Citkowicz A, Liu Y, Hayes G, Woo J, Van Nest G, Jin H, Duke G, McCormick AL. 2013. Cytomegalovirus vaccine strain Towne-derived dense bodies induce broad cellular immune responses and neutralizing antibodies that prevent infection of fibroblasts and epithelial cells. J Virol 87:11107-11120. https://doi.org/10.1128/JVI.01554-13
19. Pepperl S, Munster J, Mach M, Harris JR, Plachter B. 2000. Dense bodies of human cytomegalovirus induce both humoral and cellular immune responses in the absence of viral gene expression. J Virol 74:6132-6146. https://doi.org/10.1128/JVI.74.13.6132-6146.2000
20. Boshoff C, Weiss R. 2002. AIDS-related malignancies. Nat Rev Cancer 2:373-382. https://doi.org/10.1038/nrc797
21. Sunil M, Reid E, Lechowicz MJ. 2010. Update on HHV-8-associated malignancies. Curr Infect Dis Rep 12:147-154. https://doi.org/10.1007/ s11908-010-0092-5
22. Neparidze N, Lacy J. 2014. Malignancies associated with Epstein-Barr virus: pathobiology, clinical features, and evolving treatments. Clin Adv Hematol Oncol 12:358-371
23. Thompson MP, Kurzrock R. 2004. Epstein-Barr virus and cancer. Clin Cancer Res 10:803-821. https://doi.org/10.1158/1078-0432.CCR-0670-3
24. Hong GK, Gulley ML, Feng WH, Delecluse HJ, Holley-Guthrie E, Kenney SC. 2005. Epstein-Barr virus lytic infection contributes to lymphoproliferative disease in a SCID mouse model. J Virol 79:13993-14003. https:// doi.org/10.1128/JVI.79.22.13993-14003.2005
25. Martin DF, Kuppermann BD, Wolitz RA, Palestine AG, Li H, Robinson CA. 1999. Oral ganciclovir for patients with cytomegalovirus retinitis treated with a ganciclovir implant. Roche Ganciclovir Study Group. N Engl J Med 340:1063-1070. https://doi.org/10.1056/NEJM199904083401402
26. Ganem D. 2006. KSHV infection and the pathogenesis of Kaposi's sarcoma. Annu Rev Pathol 1:273-296. https://doi.org/10.1146/annurev.pathol.1.110304.100133
27. Chatterjee M, Osborne J, Bestetti G, Chang Y, Moore PS. 2002. Viral IL-6-induced cell proliferation and immune evasion of interferon activity. Science 298:1432-1435. https://doi.org/10.1126/science.1074883
28. Cesarman E, Nador RG, Bai F, Bohenzky RA, Russo JJ, Moore PS, Chang Y, Knowles DM. 1996. Kaposi's sarcoma-associated herpesvirus contains G protein-coupled receptor and cyclin D homologs which are expressed in Kaposi's sarcoma and malignant lymphoma. J Virol 70:8218-8223
29. Yu YM, Black JB, Goldsmith CS, Browning PJ, Bhalla K, Offermann MK. 1999. Induction of human herpesvirus-8 DNA replication and transcription by butyrate and TPA in BCBL-1 cells. J Gen Virol 80:83-90. https:// doi.org/10.1099/0022-1317-80-1-83
30. Dai X, Gong D, Xiao Y, Wu TT, Sun R, Zhou ZH. 2015. CryoEM and mutagenesis reveal that the smallest capsid protein cements and stabilizes Kaposi's sarcoma-associated herpesvirus capsid. Proc Natl Acad Sci U S A 112:E649-E656. https://doi.org/10.1073/pnas.1420317112
31. Myoung J, Ganem D. 2011. Generation of a doxycycline-inducible KSHV producer cell line of endothelial origin: maintenance of tight latency with efficient reactivation upon induction. J Virol Methods 174:12-21. https://doi.org/10.1016/j.jviromet.2011.03.012
32. Brulois KF, Chang H, Lee AS, Ensser A, Wong LY, Toth Z, Lee SH, Lee HR, Myoung J, Ganem D, Oh TK, Kim JF, Gao SJ, Jung JU. 2012. Construction and manipulation of a new Kaposi's sarcoma-associated herpesvirus bacterial artificial chromosome clone. J Virol 86:9708-9720. https://doi.org/10.1128/JVI.01019-12
33. Pellett PE, Roizman B. 2007. The family Herpesviridae: a brief introduction, p 2479-2500. In Knipe DM, Howley PM (ed), Fields virology, 5th ed. Lippincott Williams and Wilkins, Philadelphia, PA
34. Dai X, Gong D, Wu TT, Sun R, Zhou ZH. 2014. Organization of capsidassociated tegument components in Kaposi's sarcoma-associated herpesvirus. J Virol 88:12694-12702. https://doi.org/10.1128/JVI.01509-14
35. Bechtel JT, Winant RC, Ganem D. 2005. Host and viral proteins in the virion of Kaposi's sarcoma-associated herpesvirus. J Virol 79:4952-4964. https://doi.org/10.1128/JVI.79.8.4952-4964.2005
36. Zhu FX, Chong JM, Wu L, Yuan Y. 2005. Virion proteins of Kaposi's sarcoma-associated herpesvirus. J Virol 79:800-811. https://doi.org/10.1128/JVI.79.2.800-811.2005
37. Lin X, Li X, Liang D, Lan K. 2012. MicroRNAs and unusual small RNAs discovered in Kaposi's sarcoma-associated herpesvirus virions. J Virol 86:12717-12730. https://doi.org/10.1128/JVI.01473-12
38. Jochum S, Ruiss R, Moosmann A, Hammerschmidt W, Zeidler R. 2012. RNAs in Epstein-Barr virions control early steps of infection. Proc Natl Acad Sci U S A 109:E1396-E1404. https://doi.org/10.1073/pnas.1115906109
39. Chugh PE, Sin SH, Ozgur S, Henry DH, Menezes P, Griffith J, Eron JJ, Damania B, Dittmer DP. 2013. Systemically circulating viral and tumorderived microRNAs in KSHV-associated malignancies. PLoS Pathog 9:e1003484. https://doi.org/10.1371/journal.ppat.1003484
40. Chandran B. 2010. Early events in Kaposi's sarcoma-associated herpesvirus infection of target cells. J Virol 84:2188-2199. https://doi.org/10.1128/JVI.01334-09
41. Vieira J, O'Hearn PM. 2004. Use of the red fluorescent protein as a marker of Kaposi's sarcoma-associated herpesvirus lytic gene expression. Virology 325:225-240. https://doi.org/10.1016/j.virol.2004.03.049
42. Liu Y, Cao Y, Liang D, Gao Y, Xia T, Robertson ES, Lan K. 2008. Kaposi's sarcoma-associated herpesvirus RTA activates the processivity factor ORF59 through interaction with RBP-Jκ and a cis-acting RTA responsive element. Virology 380:264-275. https://doi.org/10.1016/j.virol.2008.08.011
43. Song MJ, Li XD, Brown HJ, Sun R. 2002. Characterization of interactions between RTA and the promoter of polyadenylated nuclear RNA in Kaposi's sarcoma-associated herpesvirus/human herpesvirus 8. J Virol 76:5000-5013. https://doi.org/10.1128/JVI.76.10.5000-5013.2002
44. Song MJ, Deng H, Sun R. 2003. Comparative study of regulation of RTA-responsive genes in Kaposi's sarcoma-associated herpesvirus/ human herpesvirus 8. J Virol 77:9451-9462. https://doi.org/10.1128/JVI.77.17.9451-9462.2003
45. Kypriotou M, Huber M, Hohl D. 2012. The human epidermal differentiation complex: cornified envelope precursors, S100 proteins and the 'fused genes' family. Exp Dermatol 21:643-649. https://doi.org/10.1111/ j.1600-0625.2012.01472.x
46. Shaffer AL, Lin KI, Kuo TC, Yu X, Hurt EM, Rosenwald A, Giltnane JM, Yang L, Zhao H, Calame K, Staudt LM. 2002. Blimp-1 orchestrates plasma cell differentiation by extinguishing the mature B cell gene expression program. Immunity 17:51-62. https://doi.org/10.1016/S1074-7613(02) 00335-7
47. Bikoff EK, Morgan MA, Robertson EJ. 2009. An expanding job description for Blimp-1/PRDM1. Curr Opin Genet Dev 19:379-385. https://doi.org/ 10.1016/j.gde.2009.05.005
48. Johnson AS, Maronian N, Vieira J. 2005. Activation of Kaposi's sarcomaassociated herpesvirus lytic gene expression during epithelial differentiation. J Virol 79:13769-13777. https://doi.org/10.1128/JVI.79.21.13769-13777.2005
49. Reusch JA, Nawandar DM, Wright KL, Kenney SC, Mertz JE. 2015. Cellular differentiation regulator BLIMP1 induces Epstein-Barr virus lytic reactivation in epithelial and B cells by activating transcription from both the R and Z promoters. J Virol 89:1731-1743. https://doi.org/10.1128/JVI.02781-14
50. Wilson SJ, Tsao EH, Webb BLJ, Ye HT, Dalton-Griffin L, Tsantoulas C, Gale CV, Du MQ, Whitehouse A, Kellam P. 2007. X box binding protein XBP-1s transactivates the Kaposi's sarcoma-associated herpesvirus (KSHV) ORF50 promoter, linking plasma cell differentiation to KSHV reactivation from latency. J Virol 81:13578-13586. https://doi.org/10.1128/JVI.01663-07
51. Yu FQ, Feng JY, Harada JN, Chanda SK, Kenney SC, Sun R. 2007. B cell terminal differentiation factor XBP-1 induces reactivation of Kaposi's sarcoma-associated herpesvirus. FEBS Lett 581:3485-3488. https://doi.org/10.1016/j.febslet.2007.06.056
52. Temme S, Eis-Hubinger AM, McLellan AD, Koch N. 2010. The herpes simplex virus-1 encoded glycoprotein B diverts HLA-DR into the exosome pathway. J Immunol 184:236-243. https://doi.org/10.4049/ jimmunol.0902192
53. Dargan DJ, Subak-Sharpe JH. 1997. The effect of herpes simplex virus type 1 L-particles on virus entry, replication, and the infectivity of naked herpesvirus DNA. Virology 239:378-388. https://doi.org/10.1006/viro.1997.8893
54. Heilingloh CS, Kummer M, Muhl-Zurbes P, Drassner C, Daniel C, Klewer M, Steinkasserer A. 2015. L particles transmit viral proteins from herpes simplex virus 1-infected mature dendritic cells to uninfected bystander cells, inducing CD83 downmodulation. J Virol 89:11046-11055. https:// doi.org/10.1128/JVI.01517-15
55. Yasuda T, Kometani K, Takahashi N, Imai Y, Aiba Y, Kurosaki T. 2011. ERKs induce expression of the transcriptional repressor Blimp-1 and subsequent plasma cell differentiation. Sci Signal 4:ra25. https://doi.org/10.1126/scisignal.2001592
56. Calame K. 2008. Activation-dependent induction of Blimp-1. Curr Opin Immunol 20:259-264. https://doi.org/10.1016/j.coi.2008.04.010
57. Sharma-Walia N, Krishnan HH, Naranatt PP, Zeng L, Smith MS, Chandran B. 2005. ERK1/2 and MEK1/2 induced by Kaposi's sarcoma-associated herpesvirus (human herpesvirus 8) early during infection of target cells are essential for expression of viral genes and for establishment of infection. J Virol 79:10308-10329. https://doi.org/10.1128/JVI.79.16.10308-10329.2005
58. Sadagopan S, Sharma-Walia N, Veettil MV, Raghu H, Sivakumar R, Bottero V, Chandran B. 2007. Kaposi's sarcoma-associated herpesvirus induces sustained NF-κB activation during de novo infection of primary human dermal microvascular endothelial cells that is essential for viral gene expression. J Virol 81:3949-3968. https://doi.org/10.1128/JVI.02333-06
59. Deng H, Liang Y, Sun R. 2007. Regulation of KSHV lytic gene expression. Curr Top Microbiol Immunol 312:157-183
60. Sun R, Lin SF, Gradoville L, Yuan Y, Zhu F, Miller G. 1998. A viral gene that activates lytic cycle expression of Kaposi's sarcoma-associated herpesvirus. Proc Natl Acad Sci U S A 95:10866-10871. https://doi.org/10.1073/ pnas.95.18.10866
61. Gong D, Wu NC, Xie Y, Feng J, Tong L, Brulois KF, Luan H, Du Y, Jung JU, Wang CY, Kang MK, Park NH, Sun R, Wu TT. 2014. Kaposi's sarcomaassociated herpesvirus ORF18 and ORF30 are essential for late gene expression during lytic replication. J Virol 88:11369-11382. https://doi.org/10.1128/JVI.00793-14
62. Qi J, Han C, Gong D, Liu P, Zhou S, Deng H. 2015. Murine gammaherpesvirus 68 ORF48 is an RTA-responsive gene product and functions in both viral lytic replication and latency during in vivo infection. J Virol 89:5788-5800. https://doi.org/10.1128/JVI.00406-15
63. Gong D, Kim YH, Xiao Y, Du Y, Xie Y, Lee KK, Feng J, Farhat N, Zhao D, Shu S, Dai X, Chanda SK, Rana TM, Krogan NJ, Sun R, Wu TT. 2016. A herpesvirus protein selectively inhibits cellular mRNA nuclear export. Cell Host Microbe 20:642-653. https://doi.org/10.1016/j.chom.2016.10.004
64. Trapnell C, Pachter L, Salzberg SL. 2009. TopHat: discovering splice junctions with RNA-Seq. Bioinformatics 25:1105-1111. https://doi.org/10.1093/bioinformatics/btp120
65. Vlachos IS, Zagganas K, Paraskevopoulou MD, Georgakilas G, Karagkouni D, Vergoulis T, Dalamagas T, Hatzigeorgiou AG. 2015. DIANA-miRPath v3.0: deciphering microRNA function with experimental support. Nucleic Acids Res 43:W460-W466. https://doi.org/10.1093/nar/gkv403